Deletion of the M6P/ICF2r gene in primary hepatocellular carcinoma

Cancer Letters

Volumn 120, Issue 1, 1997, Pages 39-43

  Piao, Zhe ^a   Choi, Youjeong ^a   Park, Chanil ^a   Lee, Woo Jung ^a   Park, Jeon Han ^a   Kim, Hoguen ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Hepatocellular carcinoma; M6P IGF2 receptor; Tumor suppressor gene

Indexed keywords

MANNOSE 6 PHOSPHATE; SOMATOMEDIN B RECEPTOR; DNA; DNA BINDING PROTEIN; SMAD4 PROTEIN; SMAD4 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ARTICLE; AUTORADIOGRAPHY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; GENE DELETION; GENE FREQUENCY; GENE FUNCTION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; CHROMOSOME 6; GENETICS; LIVER TUMOR; PATHOLOGY;

CARCINOMA, HEPATOCELLULAR; CHROMOSOMES, HUMAN, PAIR 6; DINUCLEOTIDE REPEATS; DNA, NEOPLASM; DNA-BINDING PROTEINS; GENE DELETION; HUMANS; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; RECEPTOR, IGF TYPE 2; SMAD4 PROTEIN; TRANS-ACTIVATORS;

EID: 0030609202     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00289-9     Document Type: Article

References (31)

1. Simonetti R.G., Camma C., Fiorello F., Politti F., D'Amico G., Pagliaro L. Hepatocellular carcinoma: a worldwide problem and the major risk factors. Dig. Dis. Sci. 36:1991;962-972.
2. Harris C.C. Hepatocellular carcinogenesis: recent advances and speculations. Cancer Cells. 2:1990;146-148.
3. Wang H.P., Rogler C.E. Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas. Cytogenet. Cell Genet. 48:1988;72-78.
4. Buetow K.H., Murray J.C., Israel J.L., London W.T., Smith M., Kew M., Blanquet V., Brechot C., Redeker A., Govindarajan S. Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA. 86:1989;8852-8856.
5. Tsuda H., Zhang W., Shimosato Y., Yokota J., Terada M., Sugimura T., Miyamura T., Hirohashi S. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA. 87:1990;6791-6794.
6. Fujimori M., Tokino T., Hino O., Kitakawa T., Imamura T., Okamoto E., Mitsunobu M., Ishikawa T., Nakagama H., Haraka H., Yaguta M., Matsubara K., Nakamura Y. Allelotype study of primary hepatocellular carcinoma. Cancer Res. 51:1991;89-93.
7. Walker G.J., Hayward N.K., Falvey S., Cooksley W.G.E. Loss of somatic heterozygosity in hepatocellular carcinoma. Cancer Res. 51:1991;4367-4370.
8. Oda T., Tsuda H., Scarpa A., Sakamoto M., Hirohashi S. p53 gene mutation spectrum in hepatocellular carcinoma. Cancer Res. 52:1992;6358-6364.
9. Konishi M., Yanoshita R.K., Tanaka K., Sato C., Tsuruta K., Maeda Y., Koike M., Tanaka S., Nakamura Y., Hattori N., Miyaki M. Genetic change and histopathological grades in human hepatocellular carcinomas. Jpn. J. Cancer Res. 84:1993;893-899.
10. Kuroki T., Fujiwara Y., Tsuchiya E., Nakamori S., Imaoka S., Kanematsu T., Nakamura Y. Accumulation of genetic changes during development and progression of hepatocellular carcinoma: loss of heterozygosity on chromosome arm 1p occurs at an early stage of hepatocarcinogenesis. Gene Chromosome Cancer. 13:1995;163-167.
11. Yumoto Y., Hanafusa T., Hada H., Morita T., Ooguchi S., Shinji N., Mitani T., Hamaya K., Koide N., Tsuji T. Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma. J. Gastroenterol. Hepatol. 10:1995;179-185.
12. Murakami Y., Hayashi K., Hirohashi S., Sekiya T. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res. 51:1991;5520-5525.
13. Fujimoto Y., Hampton L.L., Wirth P.J., Wang N.J., Xie J.P., Thorgeirsson S.S. Alterations of tumor suppressor gene and allelic losses in human hepatocellular carcinomas in China. Cancer Res. 54:1994;281-285.
14. Zhang X., Xu H.J., Murakami Y., Sachse R., Yashima K., Hirohashi S., Hu S.X., Benedict W.F., Sekiya T. Deletions of chromosome 13q, mutations in retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res. 54:1994;4177-4182.
15. Dennis P.A., Rifkin D.B. Cellular activation of latent transforming growth factor β requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc. Natl. Acad. Sci. USA. 88:1991;580-584.
16. Komfeld S. Structure and function of the mannose 6-phosphate/insulin growth factor II receptors. Annu. Rev. Biochem. 61:1992;307-330.
17. De Souza A.T., Hankins G.R., Washington M.K., Orton T.C., Jirtle R.L. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat. Genet. 11:1995;447-449.
18. Hankins G.R., De Souza A.T., Bentley R.C., Patel M.R., Marks J.R., Iglehart J.D., Jirtle R.L. M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene. 12:1996;2003-2009.
19. Nawroz H., van der Riet P., Hruban R.H., Koch W., Ruppert M., Sidransky D. Allelotype of head and neck squamous cell carcinoma. Cancer Res. 54:1994;1152-1154.
20. Goto J., Figlewicz D.A., Marineau C., Khodr N., Rouleau G.A. Dinucleotide repeat polymorphism at the IGF2R locus. Nucleic Acids Res. 20:1992;923.
21. Zulueta G.M., Shibata A., Ohneseit F.P., Spruck III H.C., Busch C., Shama M., Elbaz M., Nichols W.P., Gonzalgo L.M., Malmstrom U.P., Jones A.P. High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder. J. Natl. Cancer Inst. 87:1995;1383-1393.
22. Zhang S.Y., Klein-Szanto A.J.P., Sauter E.R., Shafarenko M., Mitsunaga S., Nobori T., Carson D.A., Ridge J.A., Goodrow T.L. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res. 54:1994;5050-5053.
23. Hahn S.A., Seymour A.B., Hoque A.T.M.S., Schutte M., da Costa L.T., Redston M.S., Caldas C., Weinstein C.L., Fischer A., Yeo C.J., Hruban R.H., Kern S.E. Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res. 55:1996;4670-4675.
24. Edmondson H.A., Steiner P.E. Primary carcinoma of the liver. A study of 100 cases among 48 900 necropsies. Cancer. 7:1954;462-503.
25. Hol F.A., Geurds M.P.A., Hamel B.C.J., Mariman E.C.M. Improving the polymorphism content of the 3′ UTR of the human IGF2R gene. Hum. Mol. Genet. 1:1992;374.
26. Laureys G., Barton D.E., Ullrich A., Francke U. Chromosomal mapping of the gene for the type II insulin-like growth factor receptor/cation-independent mannose 6-phosphate receptor in man and mouse. Genomics. 3:1988;224-229.
27. Lee J.H., Kavanagh J.J., Wildrick D.M., Wharton J.T., Blick M. Frequent loss of heterozygosity on chromosome 6q, 11, and 17 in human ovarian carcinomas. Cancer Res. 50:1990;2724-2728.
28. Saito S., Saito H., Koi S., Sagae S., Kudo R., Saito J., Noda K., Nakamura Y. Fine-scale deletion mapping of the distal long arm of chromosome 6 in 70 human ovarian cancers. Cancer Res. 52:1992;5815-5817.
29. Morita R., Saito S., Ishikawa J., Ogawa O., Yoshida O., Yamakawa K., Nakamura Y. Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma. Cancer Res. 51:1991;5817-5820.
30. Millikin D., Meese E., Vogelstein B., Witkowski C., Trent J. Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res. 51:1991;5449-5453.
31. Gaidano G., Hauptschein R.S., Parsa N.Z., Offit K., Rao P.H., Lenoir G., Knowles D.M., Chaganti R.S., Dalla-Favera R. Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma. Blood. 7:1992;1781-1787.